<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0207878.ref019">
 <label>19</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Pitisuttithum</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Gilbert</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Gurwith</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Heyward</surname>
   <given-names>W</given-names>
  </name>, 
  <name>
   <surname>Martin</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>van Griensven</surname>
   <given-names>F</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand</article-title>. 
  <source>The Journal of infectious diseases</source>; 
  <year>2006</year>;
  <volume>194</volume>(
  <issue>12</issue>):
  <fpage>1661</fpage>â€“
  <lpage>71</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1086/508748" xmlns:xlink="http://www.w3.org/1999/xlink">10.1086/508748</ext-link>
  <?supplied-pmid 17109337?>
  <pub-id pub-id-type="pmid">17109337</pub-id>
 </mixed-citation>
</ref>
